Agios Pharmaceuticals Inc to Discuss Data from ClarIDHy Study Presented at ESMO - Conference Call Transcript
Ladies and gentlemen, thank you for standing by, and welcome to the Agios Pharmaceuticals Live Webcast from ESMO Conference Call. (Operator Instructions)
I would now like to hand the conference over to your speaker today, Kendra Adams. Thank you. Please go ahead, ma'am.
Hello, everyone, and welcome to Agios' 2019 conference call from ESMO. You can access slides for today's call by going to the Investors section of our website.
With me on the call today are Dr. Jackie Fouse, our Chief Executive Officer; Dr. Susan Pandya, our VP of Clinical Development, who will provide an overview of cholangiocarcinoma; Dr. Andrew Zhu, Professor of Medicine at Harvard Medical School and Attending Oncologist at MGH, who will review the ClarIDHy Phase III data; Dr. Chris Bowden, our Chief Medical Officer will also be available for Q&A.
Before we get started, I'd like to remind everyone that statements we make on this call will include forward-looking statements.
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
